Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Comply with the diagnostic criteria for general type COVID-19 in the "Diagnosis and Treatment Program for COVID-19"(trial Inclusion criteria version 5th)
Exclusion criteria
Exclusion criteria: 1. Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route; 2. Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19; 3. Maternal, or patients with a positive urine pregnancy test; 4. People with malignant tumors, mental diseases and other systemic malignant diseases; 5. Those who are allergic to the test drug and those who are intolerant to the drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| rate of survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical and chemical indicators improvement time;Course of disease;time of hospitalization;Nucleic acid negative time;Time to improve clinical symptoms; | — |
Countries
China
Contacts
Public ContactWang Yanping
Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences
Outcome results
None listed